← All Sponsors
SPONSOR

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Influenza
NCT06574503 Phase 3
Recruiting

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

Influenza
China View Trial →